Meta tags:
description=Intellectual Property Today, published monthly since 1994, focuses on legal issues in patent, trademark and copyright law. Content is geared to the patent attorneys and agents, professionals and executives in firms and companies that provide products and services to this industry.;
keywords=intellectual property today, iptoday, www.iptoday.com, intellectual property, patent, patents, legal issues, trademark, copyright, rfc, cafc;

Headings (most frequently used words):

histogen, method, of, generating, multipotent, stem, cells, receives, us, patent,

Text of the page (most frequently used words):
and (23), the (21), cells (15), histogen (14), stem (13), patent (9), #multipotent (8), for (7), cell (7), technology (6), company (6), products (6), news (5), conditions (4), that (4), through (4), process (4), proteins (4), growth (4), express (3), jobs (3), issues (3), today (3), firms (3), including (3), low (3), oxygen (3), factors (3), which (3), has (3), with (3), medical (3), therapies (3), rfc (2), contact (2), links (2), subscribe (2), poster (2), reports (2), classified (2), home (2), 2015 (2), intellectual (2), property (2), back (2), science (2), regenerative (2), medicine (2), developing (2), proprietary (2), embryonic (2), this (2), newborn (2), are (2), naturally (2), from (2), developed (2), product (2), stimulating (2), complex (2), human (2), have (2), shown (2), differentiation (2), www (2), com (2), soluble (2), insoluble (2), hair (2), currently (2), being (2), uniquely (2), well (2), into (2), without (2), secrete (2), both (2), ethical (2), their (2), benefits (2), our (2), issued (2), method (2), fibroblast (2), trademark (2), top (2), sitemap, terms, use, privacy, policy, legal, statement, copyright, sequence, searching, listing, situations, wanted, translations, drafting, searches, law, expert, witness, blogs, executive, search, sale, auction, looking, solutions, based, upon, grown, under, mimic, environment, suspension, unique, encouraged, produce, vital, its, rich, portfolio, focuses, patient, own, delivering, been, support, more, information, please, visit, http, about, compositions, make, numerous, applications, lead, hsc, success, two, sponsored, clinical, trials, injectable, treatment, alopecia, addition, conditioned, media, produced, can, found, regenica, line, skincare, distributed, suneva, partnership, obagi, further, indications, materials, include, oncology, orthopedics, able, begin, fibroblasts, safe, established, non, controversial, source, convert, genetic, manipulation, key, markers, oct4, sox2, nanog, distinctive, composition, other, known, stimulate, body, regenerate, tissues, promote, scarless, healing, current, derived, utilize, genetically, manipulated, induced, pluripotent, inherent, scientific, risk, raise, number, regulatory, still, enthusiasm, continues, build, around, potential, address, serious, aesthetic, beauty, rejuvenation, capable, harnessing, all, excitement, any, safety, sourcing, concerns, said, gail, naughton, ceo, chairman, board, issuance, adds, great, strength, value, partners, covers, triggering, special, culture, resulting, variety, molecules, basis, inc, innovative, loss, cancer, announced, united, states, office, 524, 494, entitled, tension, bfgf, generates, vitro, tuesday, september, 2013, generating, receives, click, here, advertising, opportunities, 2014, login, register, iptoday,

Text of the page (random words):
www iptoday com intellectual property today news register login home issues news classified jobs reports poster subscribe links contact rfc express 2015 top patent firms 2014 top trademark firms advertising opportunities click here back to science technology news histogen s method of generating multipotent stem cells receives us patent tuesday september 03 2013 histogen inc a regenerative medicine company developing innovative therapies for conditions including hair loss and cancer today announced that the united states patent trademark office has issued patent 8 524 494 entitled low oxygen tension and bfgf generates a multipotent stem cell from a fibroblast in vitro to the company the issued patent covers histogen s method of triggering the de differentiation of fibroblast cells into multipotent stem cells through low oxygen and special culture conditions the resulting multipotent cells naturally secrete a variety of soluble and insoluble molecules that are the basis for histogen s products histogen s process is uniquely capable of harnessing all of the benefits and excitement of stem cell therapies without any of the ethical safety or sourcing concerns said dr gail k naughton histogen ceo and chairman of the board issuance of this patent adds great strength to our technology and value to our partners and products current stem cell derived therapies utilize embryonic stem cells or genetically manipulated induced pluripotent stem cells both of which have an inherent ethical and scientific risk and raise a number of regulatory issues still enthusiasm continues to build around stem cells both for their potential to address serious medical conditions as well as their aesthetic benefits for beauty and rejuvenation through histogen s technology process the company is uniquely able to begin with newborn fibroblasts cells a safe well established and non controversial cell source and convert the cells into multipotent stem cells without genetic manipulation the cells express key stem cell markers including oct4 sox2 and nanog and secrete a distinctive composition of growth factors and other proteins known to stimulate stem cells in the body regenerate tissues and promote scarless healing it is the soluble and insoluble compositions of multipotent proteins and growth factors which make up histogen s products with numerous applications histogen s lead product hair stimulating complex hsc has shown success in two company sponsored clinical trials as an injectable treatment for alopecia in addition the human multipotent cell conditioned media produced through histogen s process can be found in the regenica line of skincare products currently being distributed by suneva medical in partnership with obagi medical products further indications of the materials currently being developed include oncology and orthopedics about histogen histogen is a regenerative medicine company developing solutions based upon the products of cells grown under proprietary conditions that mimic the embryonic environment including low oxygen and suspension through this unique technology process newborn cells are encouraged to naturally produce the vital proteins and growth factors from which the company has developed its rich product portfolio histogen s technology focuses on stimulating a patient s own stem cells by delivering a proprietary complex of multipotent human proteins that have been shown to support stem cell growth and differentiation for more information please visit http www histogen com back to science technology news looking for sale auction executive search jobs blogs expert witness ip law firms patent tm searches patent drafting patent translations situations wanted sequence searching listing copyright 2015 intellectual property today home issues news classified jobs reports poster subscribe links contact legal statement privacy policy terms of use rfc express sitemap